Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 97630 | Other Identifier | Stanford University Alternate IRB Approval Number | |
| SU-12082009-4522 | Other Identifier | Stanford University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| % necrosis post chemotherapy | his is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting | |
| overall survival and event free survival | This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. |
Not provided
Not provided
Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor Exclusion Criteria:Patients with a known diagnosis of cancer.
Not provided
Not provided
Not provided
All patients with bone x-rays suggestive of a malignant bone tumor
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Arun A Rangaswami | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | United States |
Not provided
| ID | Term |
|---|---|
| D001859 | Bone Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
tumor samples and blood